Qualgen, LLC is recalling approximately 2,940 units of Estradiol (20mg) and Testosterone (200mg) pellets packaged in 1-count 3ml amber vials. These compounded medications were distributed nationwide and are being recalled because they have incorrect or missing lot numbers and expiration dates on their labels. Labeling errors like these can prevent patients and healthcare providers from knowing if a drug is expired or being able to identify specific batches in the event of a safety concern. No injuries have been reported in connection with this recall.
Missing or incorrect expiration dates may lead to the use of medication that has lost its potency or safety over time. Without accurate lot numbers, it is also difficult for consumers to identify if their specific medication is part of a batch affected by quality or safety issues.
Healthcare provider consultation and pharmacy refund.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.